Tarsus Pharmaceuticals, Inc.

TARS

TARSTarsus Pharmaceuticals, Inc. US flag

NASDAQ Global Select

57.41

USD

-1.52

- -

2.47BMarket Cap

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-15.39	-23.28	-7.88	-30.53	-55.09	-35.97	-14.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	96.36	96.3	90.87	92.99	93.2
EBITDA Margin (%)	- -	- -	- -	-20.77	-241.66	-815.5	-65.23	-15.32
Operating Margin (%)	- -	- -	- -	-21.32	-242.92	-820.53	-65.9	-15.72
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-24.15	-240.53	-778.89	-63.16	-14.26
Profit Margin (%)	- -	- -	- -	-24.25	-240.51	-778.89	-63.16	-14.72
Net Income to Common Margin (%)	- -	- -	- -	-24.25	-240.51	-778.89	-63.16	-14.72
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	1	2	20	30	72	72
ST Debt	- -	- -	- -	1	1	- -	1	- -
LT Debt	- -	- -	1	1	19	30	72	72
Total Debt/EBITDA	- -	-0.04	-0.03	-0.16	-0.32	-0.21	-0.61	-1.05
Net Debt/EBITDA	1.75	13.6	6.25	14.46	0.84	1.37	0.19	1.61
Total Debt/EBIT	- -	-0.04	-0.03	-0.16	-0.32	-0.21	-0.6	-1.02
Net Debt/EBIT	1.74	13.48	6.23	14.09	0.83	1.36	0.19	1.57
EBITDA to Interest Expense	- -	- -	- -	- -	-30.23	-44.12	-16.03	-8.29
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-30.47	-45.82	-16.91	-9.47
EBIT to Interest Expense	- -	- -	- -	- -	-30.38	-44.39	-16.19	-8.51
Interest Expense	- -	- -	- -	- -	2	3	7	8
Common Equity/Total Assets	-57.05	-10.34	-19.1	-26.09	-47.73	-92.15	-95.55	-75.89
Long-Term Debt/Equity (%)	- -	- -	0.33	0.35	10.07	15.14	32	21.09
Long-Term Debt/Capital (%)	- -	-1.7	-1.72	-1.31	-21.93	-13.91	-24.97	-20.45
Long-Term Debt/Total Assets (%)	- -	0.17	0.32	0.33	8.53	11.23	19.06	12.89
Total Debt/Equity (%)	- -	-2.73	0.5	1.13	10.45	15.34	32.27	21.09
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt/Total Assets (%)	- -	0.28	0.48	1.06	8.85	11.38	19.22	12.89
Net Debt to Equity	173.93	965.06	-101.29	-102.76	-27.07	-99.06	-10.23	-32.38
Net Debt/Capital (%)	63.34	90.81	84.01	79.28	32.59	44.41	6.01	20.68
EBITDA	-1	-4	-27	-12	-62	-142	-119	-69
EBITDA-CapEx	-1	-4	-27	-12	-63	-148	-126	-79
Operating Income (Loss)	-1	-4	-27	-12	-63	-143	-121	-71

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	13.16	70.76	31.21	14.97	14.07	6.16	3.61	3.08
Current Ratio	13.31	70.85	31.68	15.33	14.61	6.93	4.42	3.85
Quick Ratio	13.18	70.8	31.21	14.98	14.3	6.64	4.21	3.72
CFO/Avg Current Liab	- -	-7.36	-6.81	0.44	-3.64	-4.49	-1.41	-0.12
Common Equity/Total Assets	-57.05	-10.34	-19.1	-26.09	-47.73	-92.15	-95.55	-75.89
Long-Term Debt/Equity (%)	- -	- -	0.33	0.35	10.07	15.14	32	21.09
Long-Term Debt/Capital (%)	- -	-1.7	-1.72	-1.31	-21.93	-13.91	-24.97	-20.45
Long-Term Debt/Total Assets (%)	- -	0.17	0.32	0.33	8.53	11.23	19.06	12.89
Total Debt/Equity (%)	- -	-2.73	0.5	1.13	10.45	15.34	32.27	21.09
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt/Total Assets (%)	- -	0.28	0.48	1.06	8.85	11.38	19.22	12.89
CFO/Total Liabilities	-31.61	-5.71	-352.77	30.78	-140.23	-171.52	-54.46	-5.69
CFO/CapEx	-169	-20.99	-46.36	6.4	-96.9	-21.35	-12.64	-1.26
Altman's Z-Score	-1.56	0.79	26.06	23.62	5.84	3.17	7.14	9.54

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	2.1	5.77	6.85
Days Sales Outstanding	- -	- -	- -	- -	- -	173.86	63.22	53.3
Inventory Turnover	- -	- -	- -	- -	- -	1.03	4.48	8.78
Days Inventory Outstanding	- -	- -	- -	- -	- -	355.95	81.49	41.59
Accounts Payable Turnover	- -	- -	- -	0.81	0.23	0.4	0.91	2.51
Accounts Payable Turnover Days	- -	- -	- -	447.94	1,596.45	903.57	402.17	145.2
Cash Conversion Cycle	- -	- -	- -	-447.94	-1,596.45	-373.76	-257.46	-50.31
Inventory to Cash Days	- -	- -	- -	- -	- -	-182.09	-18.26	11.71
Inventories	- -	- -	- -	- -	- -	3	3	4
Raw Materials	- -	- -	- -	- -	- -	3	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	2	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	257	462	361	595	2,082	3,421
- Cash & Cash Equivalents	2	58	168	171	72	225	95	184
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	2	20	30	72	72
Enterprise Value	-2	-58	89	293	164	398	1,863	3,076
Total Capital	-1	-6	-32	-45	-89	-214	-288	-354
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt / EV	- -	- -	0.01	0.01	0.12	0.08	0.04	0.02
EV/Sales	- -	- -	- -	5.13	6.35	22.8	10.18	6.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	78.05	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	67.5	- -	- -	- -	511.3
Diluted Market Cap	- -	- -	257	462	361	595	2,082	3,421
Diluted Enterprise Value	-2	-58	89	293	309	400	2,060	3,310
EV per Share	- -	- -	14.38	14.23	6.66	13.54	49.55	73.63
TTM Sales	- -	- -	- -	57	26	17	183	451
TTM EBITDA	-1	-4	-27	-12	-62	-142	-119	-69
TTM Operating Income	-1	-4	-27	-12	-63	-143	-121	-71
TTM Cash Flow to Firm	-1	-4	-21	4	-47	-114	-76	-4
TTM Free Cash Flow to Firm	-1	-3	-21	4	-46	-109	-69	6

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-12.4	106.71	-7.44	-5.31	-27.23	-1,319.94
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-2	-58	89	293	164	398	1,863	3,076
Low Price	- -	- -	15.32	21	10.8	11.33	18.99	38.51
EV/Sales	- -	- -	- -	5.13	6.35	22.8	10.18	6.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-6.59	-44.07	-6.54	-3.51	-11.13	-34.44
Price/Earnings High	- -	- -	-14.75	-73.38	-9.87	-5.46	-18.59	-53.63
Price/Earnings Low	- -	- -	-3.55	-31.22	-4.28	-2.45	-6.18	-24.23
Price/Book Value	- -	- -	-7.81	-9.91	-3.32	-2.43	-5.78	-8.02
Price/Book Value Average	- -	- -	-5.38	-13.06	-3.73	-1.95	-3.57	-5.36
Price/Book Value High	- -	- -	-12.04	-21.74	-5.63	-3.03	-5.97	-8.35
Price/Book Value Low	- -	- -	-2.9	-9.25	-2.44	-1.36	-1.98	-3.77
Price/Tangible Book Value	- -	- -	1.55	2.77	1.87	3.08	9.63	10.18
Price/Tangible Book Value Average	- -	- -	1.07	3.65	2.11	2.47	5.95	6.81
Price/Tangible Book Value High	- -	- -	2.38	6.09	3.18	3.84	9.94	10.6
Price/Tangible Book Value Low	- -	- -	0.57	2.59	1.38	1.72	3.3	4.79
Price/Sales	- -	- -	- -	8.11	13.98	34.1	11.38	7.58
Price/Sales Average	- -	- -	- -	10.69	15.73	27.35	7.03	5.07
Price/Sales High	- -	- -	- -	17.79	23.74	42.52	11.74	7.89
Price/Sales Low	- -	- -	- -	7.57	10.3	19.08	3.9	3.57
Price/Cash Flow	- -	- -	-12.14	123.39	-7.36	-5.06	-25.08	-274.78
Price/Cash Flow Average	- -	- -	-8.36	162.59	-8.28	-4.06	-15.49	-183.71
Price/Cash Flow High	- -	- -	-18.7	270.73	-12.5	-6.31	-25.88	-286.09
Price/Cash Flow Low	- -	- -	-4.5	115.16	-5.42	-2.83	-8.6	-129.23
Price/Free Cash Flow Average	- -	- -	-8.55	140.6	-8.37	-4.26	-16.82	-882.48
Price/Free Cash Flow High	- -	- -	-19.12	234.12	-12.63	-6.62	-28.1	-1,374.26
Price/Free Cash Flow Low	- -	- -	-4.6	99.59	-5.48	-2.97	-9.34	-620.8
EV/Sales Average	- -	- -	- -	7.71	13.74	16.18	6.91	4.82
EV/Sales High	- -	- -	- -	14.82	21.74	31.36	11.62	7.65
EV/Sales Low	- -	- -	- -	4.6	8.3	7.92	3.78	3.32
EV/EBITDA Average	1.75	13.56	-0.35	-37.14	-5.68	-1.98	-10.59	-31.47
EV/EBITDA High	1.75	13.56	-8.48	-71.36	-9	-3.85	-17.82	-49.9
EV/EBITDA Low	1.75	13.56	2.68	-22.14	-3.44	-0.97	-5.8	-21.66
EV/EBIT Average	1.74	13.45	-0.35	-36.19	-5.65	-1.97	-10.48	-30.66
EV/EBIT High	1.74	13.45	-8.45	-69.53	-8.95	-3.82	-17.64	-48.63
EV/EBIT Low	1.74	13.45	2.67	-21.57	-3.42	-0.97	-5.74	-21.11
Last Price	- -	- -	41.33	22.5	14.66	20.25	55.37	81.88
High Price	- -	- -	63.69	49.37	24.89	25.25	57.14	85.25
Enterprise Value Average	-2	-58	10	440	355	282	1,264	2,176
Enterprise Value High	-2	-58	228	845	561	547	2,126	3,451
Enterprise Value Low	-2	-58	-72	262	214	138	692	1,498

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-15.39	-23.28	-7.88	-30.53	-55.09	-35.97	-14.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	96.36	96.3	90.87	92.99	93.2
EBITDA Margin (%)	- -	- -	- -	-20.77	-241.66	-815.5	-65.23	-15.32
Operating Margin (%)	- -	- -	- -	-21.32	-242.92	-820.53	-65.9	-15.72
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-24.15	-240.53	-778.89	-63.16	-14.26
Profit Margin (%)	- -	- -	- -	-24.25	-240.51	-778.89	-63.16	-14.72
Net Income to Common Margin (%)	- -	- -	- -	-24.25	-240.51	-778.89	-63.16	-14.72
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	1	2	20	30	72	72
ST Debt	- -	- -	- -	1	1	- -	1	- -
LT Debt	- -	- -	1	1	19	30	72	72
Total Debt/EBITDA	- -	-0.04	-0.03	-0.16	-0.32	-0.21	-0.61	-1.05
Net Debt/EBITDA	1.75	13.6	6.25	14.46	0.84	1.37	0.19	1.61
Total Debt/EBIT	- -	-0.04	-0.03	-0.16	-0.32	-0.21	-0.6	-1.02
Net Debt/EBIT	1.74	13.48	6.23	14.09	0.83	1.36	0.19	1.57
EBITDA to Interest Expense	- -	- -	- -	- -	-30.23	-44.12	-16.03	-8.29
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-30.47	-45.82	-16.91	-9.47
EBIT to Interest Expense	- -	- -	- -	- -	-30.38	-44.39	-16.19	-8.51
Interest Expense	- -	- -	- -	- -	2	3	7	8
Common Equity/Total Assets	-57.05	-10.34	-19.1	-26.09	-47.73	-92.15	-95.55	-75.89
Long-Term Debt/Equity (%)	- -	- -	0.33	0.35	10.07	15.14	32	21.09
Long-Term Debt/Capital (%)	- -	-1.7	-1.72	-1.31	-21.93	-13.91	-24.97	-20.45
Long-Term Debt/Total Assets (%)	- -	0.17	0.32	0.33	8.53	11.23	19.06	12.89
Total Debt/Equity (%)	- -	-2.73	0.5	1.13	10.45	15.34	32.27	21.09
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt/Total Assets (%)	- -	0.28	0.48	1.06	8.85	11.38	19.22	12.89
Net Debt to Equity	173.93	965.06	-101.29	-102.76	-27.07	-99.06	-10.23	-32.38
Net Debt/Capital (%)	63.34	90.81	84.01	79.28	32.59	44.41	6.01	20.68
EBITDA	-1	-4	-27	-12	-62	-142	-119	-69
EBITDA-CapEx	-1	-4	-27	-12	-63	-148	-126	-79
Operating Income (Loss)	-1	-4	-27	-12	-63	-143	-121	-71

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	13.16	70.76	31.21	14.97	14.07	6.16	3.61	3.08
Current Ratio	13.31	70.85	31.68	15.33	14.61	6.93	4.42	3.85
Quick Ratio	13.18	70.8	31.21	14.98	14.3	6.64	4.21	3.72
CFO/Avg Current Liab	- -	-7.36	-6.81	0.44	-3.64	-4.49	-1.41	-0.12
Common Equity/Total Assets	-57.05	-10.34	-19.1	-26.09	-47.73	-92.15	-95.55	-75.89
Long-Term Debt/Equity (%)	- -	- -	0.33	0.35	10.07	15.14	32	21.09
Long-Term Debt/Capital (%)	- -	-1.7	-1.72	-1.31	-21.93	-13.91	-24.97	-20.45
Long-Term Debt/Total Assets (%)	- -	0.17	0.32	0.33	8.53	11.23	19.06	12.89
Total Debt/Equity (%)	- -	-2.73	0.5	1.13	10.45	15.34	32.27	21.09
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt/Total Assets (%)	- -	0.28	0.48	1.06	8.85	11.38	19.22	12.89
CFO/Total Liabilities	-31.61	-5.71	-352.77	30.78	-140.23	-171.52	-54.46	-5.69
CFO/CapEx	-169	-20.99	-46.36	6.4	-96.9	-21.35	-12.64	-1.26
Altman's Z-Score	-1.56	0.79	26.06	23.62	5.84	3.17	7.14	9.54

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	2.1	5.77	6.85
Days Sales Outstanding	- -	- -	- -	- -	- -	173.86	63.22	53.3
Inventory Turnover	- -	- -	- -	- -	- -	1.03	4.48	8.78
Days Inventory Outstanding	- -	- -	- -	- -	- -	355.95	81.49	41.59
Accounts Payable Turnover	- -	- -	- -	0.81	0.23	0.4	0.91	2.51
Accounts Payable Turnover Days	- -	- -	- -	447.94	1,596.45	903.57	402.17	145.2
Cash Conversion Cycle	- -	- -	- -	-447.94	-1,596.45	-373.76	-257.46	-50.31
Inventory to Cash Days	- -	- -	- -	- -	- -	-182.09	-18.26	11.71
Inventories	- -	- -	- -	- -	- -	3	3	4
Raw Materials	- -	- -	- -	- -	- -	3	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	2	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	257	462	361	595	2,082	3,421
- Cash & Cash Equivalents	2	58	168	171	72	225	95	184
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	2	20	30	72	72
Enterprise Value	-2	-58	89	293	164	398	1,863	3,076
Total Capital	-1	-6	-32	-45	-89	-214	-288	-354
Total Debt/Capital (%)	- -	-2.79	-2.6	-4.22	-22.75	-14.09	-25.18	-20.45
Total Debt / EV	- -	- -	0.01	0.01	0.12	0.08	0.04	0.02
EV/Sales	- -	- -	- -	5.13	6.35	22.8	10.18	6.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	78.05	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	67.5	- -	- -	- -	511.3
Diluted Market Cap	- -	- -	257	462	361	595	2,082	3,421
Diluted Enterprise Value	-2	-58	89	293	309	400	2,060	3,310
EV per Share	- -	- -	14.38	14.23	6.66	13.54	49.55	73.63
TTM Sales	- -	- -	- -	57	26	17	183	451
TTM EBITDA	-1	-4	-27	-12	-62	-142	-119	-69
TTM Operating Income	-1	-4	-27	-12	-63	-143	-121	-71
TTM Cash Flow to Firm	-1	-4	-21	4	-47	-114	-76	-4
TTM Free Cash Flow to Firm	-1	-3	-21	4	-46	-109	-69	6

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-12.4	106.71	-7.44	-5.31	-27.23	-1,319.94
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-2	-58	89	293	164	398	1,863	3,076
Low Price	- -	- -	15.32	21	10.8	11.33	18.99	38.51
EV/Sales	- -	- -	- -	5.13	6.35	22.8	10.18	6.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-6.59	-44.07	-6.54	-3.51	-11.13	-34.44
Price/Earnings High	- -	- -	-14.75	-73.38	-9.87	-5.46	-18.59	-53.63
Price/Earnings Low	- -	- -	-3.55	-31.22	-4.28	-2.45	-6.18	-24.23
Price/Book Value	- -	- -	-7.81	-9.91	-3.32	-2.43	-5.78	-8.02
Price/Book Value Average	- -	- -	-5.38	-13.06	-3.73	-1.95	-3.57	-5.36
Price/Book Value High	- -	- -	-12.04	-21.74	-5.63	-3.03	-5.97	-8.35
Price/Book Value Low	- -	- -	-2.9	-9.25	-2.44	-1.36	-1.98	-3.77
Price/Tangible Book Value	- -	- -	1.55	2.77	1.87	3.08	9.63	10.18
Price/Tangible Book Value Average	- -	- -	1.07	3.65	2.11	2.47	5.95	6.81
Price/Tangible Book Value High	- -	- -	2.38	6.09	3.18	3.84	9.94	10.6
Price/Tangible Book Value Low	- -	- -	0.57	2.59	1.38	1.72	3.3	4.79
Price/Sales	- -	- -	- -	8.11	13.98	34.1	11.38	7.58
Price/Sales Average	- -	- -	- -	10.69	15.73	27.35	7.03	5.07
Price/Sales High	- -	- -	- -	17.79	23.74	42.52	11.74	7.89
Price/Sales Low	- -	- -	- -	7.57	10.3	19.08	3.9	3.57
Price/Cash Flow	- -	- -	-12.14	123.39	-7.36	-5.06	-25.08	-274.78
Price/Cash Flow Average	- -	- -	-8.36	162.59	-8.28	-4.06	-15.49	-183.71
Price/Cash Flow High	- -	- -	-18.7	270.73	-12.5	-6.31	-25.88	-286.09
Price/Cash Flow Low	- -	- -	-4.5	115.16	-5.42	-2.83	-8.6	-129.23
Price/Free Cash Flow Average	- -	- -	-8.55	140.6	-8.37	-4.26	-16.82	-882.48
Price/Free Cash Flow High	- -	- -	-19.12	234.12	-12.63	-6.62	-28.1	-1,374.26
Price/Free Cash Flow Low	- -	- -	-4.6	99.59	-5.48	-2.97	-9.34	-620.8
EV/Sales Average	- -	- -	- -	7.71	13.74	16.18	6.91	4.82
EV/Sales High	- -	- -	- -	14.82	21.74	31.36	11.62	7.65
EV/Sales Low	- -	- -	- -	4.6	8.3	7.92	3.78	3.32
EV/EBITDA Average	1.75	13.56	-0.35	-37.14	-5.68	-1.98	-10.59	-31.47
EV/EBITDA High	1.75	13.56	-8.48	-71.36	-9	-3.85	-17.82	-49.9
EV/EBITDA Low	1.75	13.56	2.68	-22.14	-3.44	-0.97	-5.8	-21.66
EV/EBIT Average	1.74	13.45	-0.35	-36.19	-5.65	-1.97	-10.48	-30.66
EV/EBIT High	1.74	13.45	-8.45	-69.53	-8.95	-3.82	-17.64	-48.63
EV/EBIT Low	1.74	13.45	2.67	-21.57	-3.42	-0.97	-5.74	-21.11
Last Price	- -	- -	41.33	22.5	14.66	20.25	55.37	81.88
High Price	- -	- -	63.69	49.37	24.89	25.25	57.14	85.25
Enterprise Value Average	-2	-58	10	440	355	282	1,264	2,176
Enterprise Value High	-2	-58	228	845	561	547	2,126	3,451
Enterprise Value Low	-2	-58	-72	262	214	138	692	1,498

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	19	19	20	21	27	34	38	43
Diluted Weighted Avg Shares	4	2	6	21	25	29	38	42
Basic Weighted Avg Shares	4	2	6	21	25	29	38	42
Revenue per Share	- -	- -	- -	2.77	1.05	0.59	4.87	10.8
EBITDA per Share	-0.31	-1.8	-4.33	-0.58	-2.53	-4.84	-3.17	-1.66
Operating Income per Share	-0.32	-1.82	-4.35	-0.59	-2.55	-4.87	-3.21	-1.7
Basic EPS, GAAP	-0.31	-1.98	-4.32	-0.67	-2.52	-4.62	-3.07	-1.59
Basic EPS from Cont Ops	-0.31	-1.98	-4.32	-0.67	-2.52	-4.62	-3.07	-1.59
Diluted EPS, GAAP	-0.31	-1.98	-4.32	-0.67	-2.52	-4.62	-3.07	-1.59
Diluted EPS from Cont Ops	-0.31	-1.98	-4.32	-0.67	-2.52	-4.62	-3.07	-1.59
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.28	-1.55	-3.41	0.18	-1.99	-4	-2.21	-0.3
Free Cash Flow per Basic Share	-0.28	-1.63	-3.48	0.15	-2.01	-4.19	-2.38	-0.53
Cash & Equivalents per Share	0.55	24.53	27.09	8.36	8.82	7.74	7.75	9.99
Book Value per Share	-0.32	-2.55	-5.29	-2.27	-4.42	-8.33	-9.58	-10.21
Tangible Book Value per Share	-0.32	-2.54	26.74	8.11	7.84	6.57	5.75	8.04

Tarsus Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)